James J. Dignam to Dacarbazine
This is a "connection" page, showing publications James J. Dignam has written about Dacarbazine.
Connection Strength
0.214
-
Reply to M.C. Chamberlain. J Clin Oncol. 2014 May 20; 32(15):1634-5.
Score: 0.117
-
Investigating the Effect of Reirradiation or Systemic Therapy in Patients With Glioblastoma After Tumor Progression: A Secondary Analysis of NRG Oncology/Radiation Therapy Oncology Group Trial 0525. Int J Radiat Oncol Biol Phys. 2018 01 01; 100(1):38-44.
Score: 0.037
-
Variation over time and interdependence between disease progression and death among patients with glioblastoma on RTOG 0525. Neuro Oncol. 2015 Jul; 17(7):999-1006.
Score: 0.031
-
A randomized trial of bevacizumab for newly diagnosed glioblastoma. N Engl J Med. 2014 Feb 20; 370(8):699-708.
Score: 0.029